Science Explorer Back to mapMap

Most cited papers from Nova Medical (United States)

What are the most cited papers from Nova Medical (United States)?

The most cited paper from Nova Medical (United States) is "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update" (Josef S Smolen et al., 2022), with 1,921 citations. Next come "Angiotensin II for the Treatment of Vasodilatory Shock" (919) and "Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Resonance Raman Scattering (SERRS): A Review of Applications" (655).

Showing 50 of 60 papers. Every paper with more than 131 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access 10 Nov 2022 1,921
2 Angiotensin II for the Treatment of Vasodilatory Shock Ashish Kumar Khanna et al. · New England Journal of Medicine Open access 21 May 2017 919
3 Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Resonance Raman Scattering (SERRS): A Review of Applications Graeme McNay, David Eustace, W. Ewen Smith et al. · Applied Spectroscopy Aug 2011 655
4 Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Mohsen Naghavi et al. · The Lancet Open access2,463 authors Oct 2025 500
5 Proliferation control in neural stem and progenitor cells Catarina C. F. Homem, Marko Repic, Juergen A. Knoblich · Nature reviews. Neuroscience ReviewOpen access 30 Sep 2015 417
6 Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Larry R. Steranka, Donald C. Manning, Chris J. Dehaas et al. · Proceedings of the National Academy of Sciences Open access May 1988 401
7 Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis Minoru Nakamura et al. · Hepatology Open access 22 Dec 2006 368
8 Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy Eric B. Geller et al. · Epilepsia Open access 11 Apr 2017 318
9 Heme oxygenase–1 and carbon monoxide suppress autoimmune neuroinflammation Ângelo Ferreira Chora, Paulo Fontoura, Andreia Cunha et al. · Journal of Clinical Investigation Open access 26 Jan 2007 307
10 Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations Christina Duftner, Christian Dejaco, Alexandre Rocha Sepriano et al. · RMD Open ReviewOpen access Feb 2018 304
11 Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Franco Locatelli, Vanderson Rocha, Claude Chastang et al. · PubMed Jun 1999 302
12 Autoimmune acute liver failure: Proposed clinical and histological criteria R. Todd Stravitz, Jay H. Lefkowitch, Robert J. Fontana et al. · Hepatology Open access 18 Nov 2010 302
13 Idiopathic inflammatory myopathies and the anti-synthetase syndrome: A comprehensive review Michael Mähler, Frederick W. Miller, Marvin J. Fritzler · Autoimmunity Reviews Open access 11 Jan 2014 298
14 New serological markers in inflammatory bowel disease are associated with complicated disease behaviour Marc Ferrante, Liesbet Henckaerts, Marie Joossens et al. · Gut Open access 24 Apr 2007 294
15 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends María Laura Bertolaccini, Olga Amengual, Laura Andréoli et al. · Autoimmunity Reviews 10 May 2014 266
16 Individual differences in aging: Behavioral and neurobiological correlates Alicja L. Markowska, William S. Stone, Donald K. Ingram et al. · Neurobiology of Aging 1989 252
17 Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy Charles D. Kassardjian, Vanda A. Lennon, Nora B. Alfugham et al. · JAMA Neurology 20 Jul 2015 244
18 Bradykinin stimulates tumor necrosis factor and interleukin‐1 release from macrophages Carol W. Tiffany, Ronald M. Burch · FEBS Letters 24 Apr 1989 242
19 Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis Annette Magdalene Langer-Gould, Rita A. Popat, Stella Huang et al. · Archives of Neurology Dec 2006 232
20 Cholecalciferol Supplementation in Hemodialysis Patients Patrícia João Matias, Cristina Rego de Freitas Mendes Jorge, Carina Ferreira et al. · Clinical Journal of the American Society of Nephrology Open access 4 Mar 2010 222
21 COPD and Cardiovascular Disease Sandra André, Bebiana Conde, Elsa Fragoso et al. · Pulmonology Open access 7 Dec 2018 205
22 Current Concepts and Future Directions for the Assessment of Autoantibodies to Cellular Antigens Referred to as Anti-Nuclear Antibodies Michael Mähler, Pier Luigi Meroni, Xavier Bossuyt et al. · Journal of Immunology Research Open access 2014 202
23 AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC Kentaroh Yamamoto, Hiroshi Imamura, Yutaka Matsuyama et al. · Journal of Gastroenterology 12 Jul 2010 192
24 Design of a SENSE‐optimized high‐sensitivity MRI receive coil for brain imaging Jacco A. de Zwart, Patrick J. Ledden, Peter Kellman et al. · Magnetic Resonance in Medicine Open access Jun 2002 191
25 International consensus guidelines on anticardiolipin and anti–β 2 ‐glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies Gabriella Lakos, Emmanuel J. Favaloro, Edward N. Harris et al. · Arthritis & Rheumatism 27 Sep 2011 183
26 Standardized Definitions of Bleeding After Transbronchial Lung Biopsy Erik E. Folch et al. · CHEST Journal Open access 14 Feb 2020 180
27 Quantitative Autonomic Testing Péter Novák · Journal of Visualized Experiments Open access 19 Jul 2011 180
28 Soluble Fas Ligand Is Chemotactic for Human Neutrophilic Polymorphonuclear Leukocytes Luciano Carlo Ottonello, Giuseppe Tortolina, Massimo Amelotti et al. · The Journal of Immunology Open access Mar 1999 180
29 Transcatheter Mitral Valve Therapy in the United States Michael J. Mack et al. · Journal of the American College of Cardiology Open access 25 Oct 2021 179
30 Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis Zobair M. Younossi et al. · Gastroenterology Open access 11 Apr 2025 178
31 Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome María Orietta Borghi et al. · Frontiers in Immunology Open access 15 Oct 2020 177
32 Signal‐to‐noise ratio and parallel imaging performance of a 16‐channel receive‐only brain coil array at 3.0 Tesla Jacco A. de Zwart, Patrick J. Ledden, Peter van Gelderen et al. · Magnetic Resonance in Medicine Open access 29 Dec 2003 177
33 Reassessment of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Gastritis With Respect to Cobalamin Deficiency Edith Lahner, Gary L. Norman, Carola Severi et al. · The American Journal of Gastroenterology 2 Jun 2009 176
34 Perioperative Cognitive Decline in the Aging Population Niccolò Terrando, Marek Brzeziński, Vincent Degos et al. · Mayo Clinic Proceedings Open access 30 Aug 2011 176
35 IL-2 receptor alpha deficiency and features of primary biliary cirrhosis Christopher A. Aoki, Chaim M. Roifman, Zhe‐Xiong Lian et al. · Journal of Autoimmunity Aug 2006 174
36 Evidence for a pulmonary B3 bradykinin receptor. Stephen G. Farmer, Ronald M. Burch, Sonya Meeker et al. · Molecular Pharmacology Jul 1989 173
37 Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients Aníbal Ferreira, Joa[Combining Tilde]o Miguel Fraza[Combining Tilde]o, Marie Claude Monier-Faugere et al. · Journal of the American Society of Nephrology Open access 16 Jan 2008 172
38 In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy Cécile Bergua, Hélène Chiavelli, Yves F. Allenbach et al. · Annals of the Rheumatic Diseases 11 Oct 2018 170
39 HandaPhos: A General Ligand Enabling Sustainable ppm Levels of Palladium‐Catalyzed Cross‐Couplings in Water at Room Temperature Sachin Handa, Martin Andersson, Fabrice Gallou et al. · Angewandte Chemie International Edition Open access 29 Feb 2016 169
40 Gap geometry dictates epithelial closure efficiency Andrea Ravasio, Ibrahim Cheddadi, Tianchi Chen et al. · Nature Communications Open access 9 Jul 2015 167
41 Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. Umberto Dianzani, Ada Funaro, Daniela DiFranco et al. · The Journal of Immunology Aug 1994 159
42 Home telemonitoring of non-invasive ventilation decreases healthcare utilisation in a prospective controlled trial of patients with amyotrophic lateral sclerosis Anabela Cardoso Pinto, Juliano Pinheiro de Almeida, Susana Pinto et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 8 Sep 2010 158
43 Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases Michael Mähler, Todd A. Parker, Carol Peebles et al. · The Journal of Rheumatology Open access Sep 2012 157
44 Brain biocompatibility of a biodegradable, controlled‐release polymer in rats Rafael John Tamargo, Jonathan I. Epstein, Carla S. Reinhard et al. · Journal of Biomedical Materials Research Feb 1989 156
45 The legal and ethical framework governing Body Donation in Europe-1st update on current practice Beat M. Riederer, Sophie H. Bolt, Erich Brenner et al. · OAR@UM (University of Malta) Open access 2012 153
46 Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis Alexandre Rocha Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra et al. · Annals of the Rheumatic Diseases ReviewOpen access 14 Nov 2022 152
47 Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis Marie Hudson, Janet Elizabeth Pope, Michael Mähler et al. · Arthritis Research & Therapy Open access 6 Mar 2012 150
48 ‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010 María Laura Bertolaccini, Olga Amengual, Tatsuya Atsumi et al. · Lupus Feb 2011 149
49 New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort Mária Papp, István Altorjay, Nir Dotan et al. · The American Journal of Gastroenterology Mar 2008 147
50 Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study Clementina López‐Medina et al. · RMD Open Open access 2021 145

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.